Works matching Androgen drugs

Results: 288

Novel drugs targeting the androgen receptor pathway in prostate cancer.

Published in:

Cancer & Metastasis Reviews, 2014, v. 33, n. 2/3, p. 567, doi. 10.1007/s10555-013-9472-2

By:

Mateo, Joaquin;
Smith, Alan;
Ong, Michael;
Bono, Johann

Publication type:

Article

Reliability of Drug History to Verify Androgen Abuse in Men.

Published in:

Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 9, p. e3790, doi. 10.1210/clinem/dgac348

By:

Shankara-Narayana, Nandini;
Brooker, Lance;
Goebel, Catrin;
Speers, Naomi;
Handelsman, David J.

Publication type:

Article

Toxicity prediction of small drug molecules of androgen receptor using multilevel ensemble model.

Published in:

Journal of Bioinformatics & Computational Biology, 2019, v. 17, n. 5, p. N.PAG, doi. 10.1142/S0219720019500331

By:

Gupta, Vishan Kumar;
Rana, Prashant Singh

Publication type:

Article

Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.

Published in:

Cancers, 2024, v. 16, n. 19, p. 3336, doi. 10.3390/cancers16193336

By:

Leblanc, Kori;
Edwards, Scott J.;
Dranitsaris, George;
Leong, Darryl P.;
Carrier, Marc;
Malone, Shawn;
Rendon, Ricardo A.;
Bond, Alison M.;
Sitland, Troy D.;
Zalewski, Pawel;
Wang, Michelle;
Emmenegger, Urban

Publication type:

Article

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer.

Published in:

Cancers, 2021, v. 13, n. 7, p. 1534, doi. 10.3390/cancers13071534

By:

Ehsani, Marzieh;
David, Faith Oluwakemi;
Baniahmad, Aria;
Limonta, Patrizia

Publication type:

Article

Opiate-Androgen Interactions in Drug-Induced Yawning and Penile Erections in the Rat.

Published in:

Neuroendocrinology, 1986, v. 42, n. 3, p. 185, doi. 10.1159/000124438

By:

Berendsen, Hemmie H.G.;
Gower, Alma J.

Publication type:

Article

Microfluidic Assessment of Drug Effects on Physical Properties of Androgen Sensitive and Non-Sensitive Prostate Cancer Cells.

Published in:

Micromachines, 2021, v. 12, n. 5, p. 532, doi. 10.3390/mi12050532

By:

Luo, Da;
Liu, Na;
Chen, Yang;
Peng, Yan;
Yue, Tao;
Cao, Shan;
Liu, Yuanyuan;
Aoyama, Tadayoshi

Publication type:

Article

Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer.

Published in:

Ecancermedicalscience, 2014, v. 8, n. 447-473, p. 1, doi. 10.3332/ecancer.2014.459

By:

Poku, Rosemary A.;
Amissah, Felix;
Duverna, Randolph;
Aguilar, Byron J.;
Kiros, Gebre-Egziabher;
Lamango, Nazarius S.

Publication type:

Article

Mechanisms of acquired resistance to androgen receptor targeting drugs in castration-resistant prostate cancer.

Published in:

Expert Review of Anticancer Therapy, 2014, v. 14, n. 11, p. 1369, doi. 10.1586/14737140.2014.928594

By:

Chism, David D;
De Silva, Dinuka;
Whang, Young E

Publication type:

Article

Drug eruption caused by enzalutamide: A case and literature review of androgen receptor inhibitor‐related drug eruptions.

Published in:

Australasian Journal of Dermatology, 2018, v. 59, n. 2, p. e133, doi. 10.1111/ajd.12694

By:

Saito‐Sasaki, Natsuko;
Sawada, Yu;
Okada, Etsuko;
Nakamura, Motonobu

Publication type:

Article

Reduced pim-1 expression increases chemotherapeutic drug sensitivity in human androgen-independent prostate cancer cells by inducing apoptosis.

Published in:

Experimental & Therapeutic Medicine, 2019, v. 18, n. 4, p. 2731, doi. 10.3892/etm.2019.7862

By:

Zhang, Xing;
Sun, Yuyan;
Wang, Peng;
Yang, Changfu;
Li, Shengwei

Publication type:

Article

An Aminosteroid Derivative Shows Higher In Vitro and In Vivo Potencies than Gold Standard Drugs in Androgen-Dependent Prostate Cancer Models.

Published in:

Cancers, 2023, v. 15, n. 11, p. 3033, doi. 10.3390/cancers15113033

By:

Poirier, Donald;
Roy, Jenny;
Maltais, René;
Weidmann, Cindy;
Audet-Walsh, Étienne

Publication type:

Article

Can prophylactic breast irradiation contribute to cardiac toxicity in patients with prostate cancer receiving androgen suppressing drugs?

Published in:

Radiation Oncology, 2008, v. 3, p. 1, doi. 10.1186/1748-717X-3-2

By:

Nieder, Carsten;
Pawinski, Adam;
Andratschke, Nicolaus H.;
Molls, Michael

Publication type:

Article

Anti-epileptic drug phenytoin enhances androgen metabolism and androgen receptor expression in murine hippocampus.

Published in:

Journal of Neurochemistry, 2006, v. 96, n. 2, p. 460, doi. 10.1111/j.1471-4159.2005.03555.x

By:

Meyer, Ralf Peter;
Hagemeyer, Christoph Eugen;
Knoth, Rolf;
Kaufmann, Michel Rene;
Volk, Benedikt

Publication type:

Article

A magic drug target: Androgen receptor.

Published in:

Medicinal Research Reviews, 2019, v. 39, n. 5, p. 1485, doi. 10.1002/med.21558

By:

Li, Dan;
Zhou, Wenfang;
Pang, Jinping;
Tang, Qin;
Zhong, Bingling;
Shen, Chao;
Xiao, Li;
Hou, Tingjun

Publication type:

Article

Drug‐induced liver injury from selective androgen receptor modulators, anabolic‐androgenic steroids and bodybuilding supplements in Australia.

Published in:

2024

By:

Nash, Emily;
Nicoll, Amanda;
Batt, Nicholas;
George, Jacob;
Perananthan, Varan;
Prince, David;
Wallace, Michael;
Gow, Paul;
Vaz, Karl;
Chitturi, Shivakumar;
Flores, Joan Ericka;
Braund, Alicia;
Bonnichsen, Mark;
Riordan, Stephen;
Humphris, Jeremy;
Duong, Tuan;
McKenzie, Catriona;
Liu, Ken;
Strasser, Simone I.

Publication type:

Case Study

去勢抵抗性前立腺癌治療にかかる費用の検討.

Published in:

Japanese Journal of Urology / Nihon Hinyokika Gakkai Zasshi, 2021, v. 112, n. 2, p. 53

By:

西澤恒二;
八田原広大;
大西裕之;
吉田徹

Publication type:

Article

Expanding sports drug testing assays: Mass spectrometric characterization of the selective androgen receptor modulator drug candidates RAD140 and ACP-105.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2013, v. 27, n. 11, p. 1173, doi. 10.1002/rcm.6558

By:

Thevis, Mario;
Piper, Thomas;
Beuck, Simon;
Geyer, Hans;
Schänzer, Wilhelm

Publication type:

Article

Interaction of Androgens with Cardiotonic Drugs in Isolated Left Atrium of Rat.

Published in:

Pharmacology, 2004, v. 70, n. 3, p. 118, doi. 10.1159/000074974

By:

Secades, Lorena;
Cortina, Rosario;
Velasco, Lucìa;
Bordallo, Javier;
Hidalgo, Agustìn;
Sá nchez, Manuel

Publication type:

Article

Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects.

Published in:

Clinical Endocrinology, 2015, v. 82, n. 5, p. 624, doi. 10.1111/cen.12641

By:

Karavolos, Stamatios;
Reynolds, Michael;
Panagiotopoulou, Nikoletta;
McEleny, Kevin;
Scally, Michael;
Quinton, Richard

Publication type:

Article

Norfloxacin drug induces reproductive toxicity and alters androgen receptor gene expression in testes and cloacal gland of male Japanese quail ( Coturnix Japonica).

Published in:

Environmental Toxicology & Chemistry, 2013, v. 32, n. 9, p. 2134, doi. 10.1002/etc.2291

By:

Singh, Ram P.;
Sastry, Kochiganti V.H.;
Dubey, Pawan K.;
Agrawal, Radha;
Singh, Renu;
Pandey, Nitin Kumar;
Mohan, Jag

Publication type:

Article

Glycomics for Drug Discovery: Metabolic Perturbation in Androgen-Independent Prostate Cancer Cells Induced by Unnatural Hexosamine Mimics.

Published in:

Angewandte Chemie, 2012, v. 124, n. 14, p. 3442, doi. 10.1002/ange.201108742

By:

Nishimura, Shin-Ichiro;
Hato, Megumi;
Hyugaji, Satoshi;
Feng, Fei;
Amano, Maho

Publication type:

Article

Current and potential targets for drug design in the androgen receptor pathway for prostate cancer.

Published in:

Expert Opinion on Drug Discovery, 2018, v. 13, n. 6, p. 489, doi. 10.1080/17460441.2018.1455662

By:

Guddati, Achuta Kumar

Publication type:

Article

Functional and structural analysis of androgen receptors for anti-cancer drug discovery.

Published in:

Cancer Therapy, 2008, v. 6, n. 2, p. 439

By:

Nahleh, Zeina

Publication type:

Article

TAS3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer.

Published in:

Molecular Oncology, 2024, v. 18, n. 8, p. 1980, doi. 10.1002/1878-0261.13641

By:

Yoshida, Shohei;
Kajiwara, Daisuke;
Seki, Masanao;
Tayama, Manabu;
Tanaka, Yuki;
Mizutani, Hiroya;
Fujita, Ryoto;
Yamamura, Keisuke;
Okajima, Shigeo;
Asai, Masanori;
Minamiguchi, Kazuhisa

Publication type:

Article

Androgen Receptor Targeting Drugs in Castration-Resistant Prostate Cancer and Mechanisms of Resistance.

Published in:

Clinical Pharmacology & Therapeutics, 2015, v. 98, n. 6, p. 582, doi. 10.1002/cpt.256

By:

Crona, DJ;
Milowsky, MI;
Whang, YE

Publication type:

Article

Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin.

Published in:

Investigational New Drugs, 2016, v. 34, n. 4, p. 458, doi. 10.1007/s10637-016-0353-8

By:

Coss, Christopher;
Jones, Amanda;
Dalton, James

Publication type:

Article

Cardiac Glycosides Induce Resistance to Tubulin-Dependent Anticancer Drugs in Androgen-Independent Human Prostate Cancer.

Published in:

Journal of Biomedical Science, 2002, v. 9, n. 5, p. 443, doi. 10.1007/BF02256539

By:

Dong-Ming Huang, Li Q.;
Jih-Hwa Guh, Li Q.;
Yao-Ting Huang, Li Q.;
Shih-Chieh Chueh;
Hui-Po Wang, Li Q.;
Che-Ming Teng, Li Q.

Publication type:

Article

Glycomics for Drug Discovery: Metabolic Perturbation in Androgen-Independent Prostate Cancer Cells Induced by Unnatural Hexosamine Mimics.

Published in:

Angewandte Chemie International Edition, 2012, v. 51, n. 14, p. 3386, doi. 10.1002/anie.201108742

By:

Nishimura, Shin-Ichiro;
Hato, Megumi;
Hyugaji, Satoshi;
Feng, Fei;
Amano, Maho

Publication type:

Article

Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2015, v. 29, n. 11, p. 991, doi. 10.1002/rcm.7189

By:

Thevis, Mario;
Lagojda, Andreas;
Kuehne, Dirk;
Thomas, Andreas;
Dib, Josef;
Hansson, Annelie;
Hedeland, Mikael;
Bondesson, Ulf;
Wigger, Tina;
Karst, Uwe;
Schänzer, Wilhelm

Publication type:

Article

A sting in the tail: the N-terminal domain of the androgen receptor as a drug target.

Published in:

Asian Journal of Andrology, 2016, v. 18, n. 5, p. 687, doi. 10.4103/1008-682X.181081

By:

Monaghan, Amy E.;
McEwan, Iain J.

Publication type:

Article

Co-treatment with the non-steroidal anti-androgen drug, flutamide and the natural estrogen, 17β-estradiol does not lead to additive reproductive impairment in juvenile Murray rainbowfish ( Melanotaenia fluviatilis).

Published in:

Journal of Applied Toxicology, 2015, v. 35, n. 11, p. 1241, doi. 10.1002/jat.3135

By:

Bhatia, Harpreet;
Kumar, Anupama;
Du, Jun;
Chapman, John C.;
McLaughlin, Mike J.

Publication type:

Article

SNP rs9364554 Modulates Androgen Receptor Binding and Drug Response in Prostate Cancer.

Published in:

Biomolecules (2218-273X), 2025, v. 15, n. 1, p. 64, doi. 10.3390/biom15010064

By:

Yan, Yuqian;
Shi, Lei;
Ma, Tao;
Wang, Liguo;
Huang, Haojie

Publication type:

Article

Anticancer drugs: New approaches to anti-androgen activities.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 452, doi. 10.1038/nrd2903

By:

Harrison, Charlotte

Publication type:

Article

The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1α-/VEGF-signaling.

Published in:

Gynecological Endocrinology, 2015, v. 31, n. 2, p. 160, doi. 10.3109/09513590.2014.971235

By:

von Wahlde, Marie-Kristin;
Hülsewig, Carolin;
Ruckert, Christian;
Götte, Martin;
Kiesel, Ludwig;
Bernemann, Christof

Publication type:

Article

The effect of follicle-maturing drugs on mid-cycle androgen levels in women with normal baseline levels.

Published in:

Gynecological Endocrinology, 1992, v. 6, n. 2, p. 107, doi. 10.3109/09513599209046393

By:

Check, J. H.;
Dietterich, C.;
Lauer, C.;
Lurie, D.

Publication type:

Article

Can progressive site‐directed therapy prolong the efficacy of subsequent androgen receptor axis‐targeted drugs in oligometastatic castration‐resistant prostate cancer?

Published in:

International Journal of Urology, 2021, v. 28, n. 2, p. 241, doi. 10.1111/iju.14421

By:

Yoshida, Soichiro;
Takahara, Taro;
Yokoyama, Minato;
Matsuoka, Yoh;
Yoshimura, Ryoichi;
Fujii, Yasuhisa

Publication type:

Article

Fatigue, treatment satisfaction and health‐related quality of life among patients receiving novel drugs suppressing androgen signalling for the treatment of metastatic castrate‐resistant prostate cancer.

Published in:

European Journal of Cancer Care, 2019, v. 28, n. 1, p. N.PAG, doi. 10.1111/ecc.12949

By:

Dearden, Lindsay;
Shalet, Natalie;
Artenie, Cristiana;
Mills, Andrew;
Jackson, Claire;
Grant, Laura;
Gater, Adam

Publication type:

Article

Androgen receptor outwits prostate cancer drugs.

Published in:

Nature Medicine, 2004, v. 10, n. 1, p. 26, doi. 10.1038/nm0104-26

By:

Isaacs, John T.;
Isaacs, William B.

Publication type:

Article

Part B data reveal increased usage of denosumab and mitomycin: Leuprolide acetate remains the most commonly used androgen suppression drug.

Published in:

Urology Times, 2021, v. 49, n. 4, p. 37

By:

DOWLING, ROBERT A.

Publication type:

Article

miR-141-3p、KLF9 异常表达对前列腺癌细胞株药物敏感性和雄激素受体表达的影响及靶向关系.

Published in:

Shandong Medical Journal, 2024, v. 64, n. 15, p. 1, doi. 10.3969/j.issn.1002-266X.2024.15.001

By:

刘彼得;
靳宏勇;
王书恒;
李循;
李九智

Publication type:

Article

A partially open conformation of an androgen receptor ligand‐binding domain with drug‐resistance mutations.

Published in:

Acta Crystallographica: Section F, Structural Biology Communications, 2023, v. 79, n. 4, p. 95, doi. 10.1107/S2053230X23002224

By:

Doamekpor, Selom K.;
Peng, Panfeng;
Xu, Ruo;
Ma, Liandong;
Tong, Youzhi;
Tong, Liang

Publication type:

Article

Selective Androgen Receptor Modulators—Transformative Drugs or Heralds of the Next Drug Epidemic?

Published in:

JAMA: Journal of the American Medical Association, 2024, v. 331, n. 16, p. 1359, doi. 10.1001/jama.2024.1769

By:

Hahamyan, Henrik A.;
Basaria, Shehzad

Publication type:

Article

Phase I/II trials of anti-androgen drugs show promise for patients with advanced prostate cancer.

Published in:: Cancer Biology & Therapy, 2009, v. 8, n. 8, p. 661, doi. 10.4161/cbt.8.8.8776
Publication type:: Article

Safety of important dermatological drugs (retinoids, immune suppressants, anti androgens and thalidomide) in reproductively active males with respect to pregnancy outcome: A brief review of literature.

Published in:

2018

By:

Kumar, Piyush;
Das, Anupam;
Lal, Niharika Ranjan;
Jain, Sourabh;
Ghosh, Anupama

Publication type:

journal article

Earlier use of androgen receptor-axis-targeted drugs may improve overall survival in patients with non-metastatic castration-resistant prostate cancer.

Published in:

Prostate, 2018, v. 78, n. 10, p. 766, doi. 10.1002/pros.23534

By:

Mori, Keiichiro;
Kimura, Takahiro;
Ito, Kagenori;
Onuma, Hajime;
Tanaka, Masatoshi;
Matsuura, Taishi;
Kurokawa, Gaku;
Iwatani, Kosuke;
Inaba, Yuzo;
Sakanaka, Keigo;
Sasaki, Hiroshi;
Miki, Jun;
Shimomura, Tatsuya;
Miki, Kenta;
Egawa, Shin

Publication type:

Article

PLCε knockdown overcomes drug resistance to androgen receptor antagonist in castration‐resistant prostate cancer by suppressing the wnt3a/β‐catenin pathway.

Published in:

Journal of Cellular Physiology, 2019, v. 234, n. 9, p. 15472, doi. 10.1002/jcp.28195

By:

Li, Luo;
Du, Zhongbo;
Gao, Yingying;
Tang, Yu;
Fan, Yanru;
Sun, Wei;
Li, Ting;
Liu, Nanjing;
Yuan, Mengjuan;
Fan, Jiaxin;
Niu, Lingfang;
Yan, Jinxiao;
Duan, Limei;
Wu, Xiaohou;
Luo, Chunli

Publication type:

Article

A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 2, p. 195, doi. 10.1111/bcpt.13499

By:

Tian, Jing‐Yan;
Chi, Chang‐Liang;
Bian, Ge;
Guo, Feng‐Jun;
Wang, Xiao‐Qing;
Yu, Bing

Publication type:

Article

Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride.

Published in:

Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-19249-z

By:

Xiao, Qingpin;
Wang, Lei;
Supekar, Shreyas;
Shen, Tao;
Liu, Heng;
Ye, Fei;
Huang, Junzhou;
Fan, Hao;
Wei, Zhiyi;
Zhang, Cheng

Publication type:

Article

An early detection of prostate cancer drug in water to prevent loss of biodiversity.

Published in:

Process Safety & Environmental Protection: Transactions of the Institution of Chemical Engineers Part B, 2021, v. 151, p. 51, doi. 10.1016/j.psep.2021.05.002

By:

Kannan, Aarthi;
Venkatesvaran, Harikrishnan;
Ananthakrishnan, Dhurkasini;
Mayavan, Abinaya;
Gandhi, Sakthivel

Publication type:

Article